HIC
PFE icon

Hamrick Investment Counsel’s Pfizer PFE Stock Holding History

Hamrick Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Sell
47,457
-5,689
-11% -$149K 0.76% 34
2026
Q1 		$1.49M Buy
53,146
+10,340
+24% +$275K 0.83% 31
2025
Q4 		$1.07M Buy
+42,806
New +$1.08M 0.79% 36

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hamrick Investment Counsel's PFE Position: Q2 2026 in Review

Hamrick Investment Counsel reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $149K and leaving 47,457 shares worth $1.14M. The position accounts for 0.76% of the portfolio, ranked #34.

Hamrick Investment Counsel first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.49M in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hamrick Investment Counsel held 47,457 shares of Pfizer worth $1.14M as of Q2 2026.
  • Hamrick Investment Counsel sold 5,689 Pfizer shares in Q2 2026, an estimated $149K.
  • Pfizer made up 0.76% of Hamrick Investment Counsel's portfolio in Q2 2026, its #34 holding.
  • Hamrick Investment Counsel first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Hamrick Investment Counsel's Pfizer position peaked at $1.49M in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hamrick Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.